NN Investment Partners Holdings’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$7.37M Buy
30,399
+503
+2% +$122K 0.04% 336
2021
Q4
$7.79M Sell
29,896
-4,471
-13% -$1.16M 0.04% 341
2021
Q3
$9.06M Sell
34,367
-8,708
-20% -$2.38M 0.05% 294
2021
Q2
$10.6M Buy
43,075
+7,150
+20% +$1.5M 0.06% 276
2021
Q1
$6.97M Buy
35,925
+3,020
+9% +$606K 0.04% 340
2020
Q4
$6.99M Buy
32,905
+2,337
+8% +$466K 0.04% 317
2020
Q3
$5.24M Sell
30,568
-1,192
-4% -$220K 0.03% 337
2020
Q2
$6.1M Buy
31,760
+3,914
+14% +$640K 0.04% 309
2020
Q1
$4.1M Sell
27,846
-17,305
-38% -$2.76M 0.03% 340
2019
Q4
$7M Sell
45,151
-22,644
-33% -$3.26M 0.05% 322
2019
Q3
$9.16M Sell
67,795
-104,966
-61% -$13.8M 0.07% 237
2019
Q2
$21.1M Sell
172,761
-69,162
-29% -$7.66M 0.17% 132
2019
Q1
$25.2M Sell
241,923
-10,750
-4% -$1.11M 0.2% 116
2018
Q4
$28.8M Buy
252,673
+77,987
+45% +$8.36M 0.24% 99
2018
Q3
$20.1M Buy
174,686
+146,054
+510% +$16M 0.15% 146
2018
Q2
$2.97M Sell
28,632
-72,000
-72% -$7.29M 0.02% 388
2018
Q1
$9.91M Buy
100,632
+13,889
+16% +$1.31M 0.07% 216
2017
Q4
$7.35M Hold
86,743
0.05% 247
2017
Q3
$6.67M Buy
86,743
+85,651
+7,843% +$6.55M 0.04% 286
2017
Q2
$85K Buy
1,092
+300
+38% +$21.5K ﹤0.01% 806
2017
Q1
$57K Hold
792
﹤0.01% 770
2016
Q4
$49K Hold
792
﹤0.01% 822
2016
Q3
$51K Sell
792
-78,771
-99% -$5.24M ﹤0.01% 796
2016
Q2
$5.03M Sell
79,563
-89,093
-53% -$5.25M 0.05% 228
2016
Q1
$9.75M Buy
+168,656
New +$9.55M 0.09% 175

Other funds holding RMD

NN Investment Partners Holdings's RMD Position: Q1 2022 in Review

NN Investment Partners Holdings increased its ResMed (RMD) stake by 1.7% in Q1 2022, buying an estimated $122K and bringing the position to 30,399 shares worth $7.37M. The position accounts for 0.04% of the portfolio, ranked #336.

NN Investment Partners Holdings first reported a position in RMD in Q1 2016 and has held it in 25 quarters since. The position peaked at $28.8M in Q4 2018. 683 funds tracked by Wall St. Rank hold RMD as of Q1 2022.

  • NN Investment Partners Holdings held 30,399 shares of ResMed worth $7.37M as of Q1 2022.
  • NN Investment Partners Holdings bought 503 ResMed shares in Q1 2022, an estimated $122K.
  • ResMed made up 0.04% of NN Investment Partners Holdings's portfolio in Q1 2022, its #336 holding.
  • NN Investment Partners Holdings first reported a position in ResMed in Q1 2016 and has held it in 25 quarters since.
  • NN Investment Partners Holdings's ResMed position peaked at $28.8M in Q4 2018.
  • 683 funds tracked by Wall St. Rank held ResMed as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.